Choroidal vascular index has no predictive value on the frequency of intravitreal anti-vascular endothelial growth factor applications in diabetic retinopathy

被引：0
|
作者：
Park, James [1 ]
Vyas, Charu [1 ]
Gucer, Doru [1 ]
Inam, Onur [1 ]
Tezel, Tongalp H. [1 ]
机构：
[1] Columbia Univ, Dept Ophthalmol, Vagelos Coll Phys & Surg, New York, NY 10027 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6226
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-vascular endothelial growth factor for diabetic macular oedema
    Virgili, Gianni
    Parravano, Mariacristina
    Menchini, Francesca
    Evans, Jennifer R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [42] Persistent Angiographic Abnormalities After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
    Shah, Neepa
    Gupta, Mrinali P.
    Chan, R. V. Paul
    JAMA OPHTHALMOLOGY, 2018, 136 (04) : 436 - 437
  • [43] Addition of photodynamic therapy to anti-vascular endothelial growth factor drugs compared to anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy
    Manzur Yarur, Franco
    Meza V, Victor
    Garreton C, Rodolfo
    Munoz Q, Aldo
    MEDWAVE, 2021, 21 (08):
  • [44] A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
    Young, Benjamin K.
    Hwang, Min
    Johnson, Mark W.
    Besirli, Cagri G.
    Wubben, Thomas J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 243 : 77 - 82
  • [45] Application of Anti-Vascular Endothelial Growth Factor Drug Conbercept to Treatment of Proliferative Diabetic Retinopathy
    Zhan, Dongmei
    Zhao, Juan
    Lou, Juan
    Fan, Xin
    Wang, Weiling
    Shi, Qin
    Ma, Yaling
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (10): : 2363 - 2368
  • [46] Panretinal Photocoagulation vs Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy Reply
    Gross, Jeffrey G.
    Glassman, Adam R.
    JAMA OPHTHALMOLOGY, 2016, 134 (06) : 716 - 716
  • [47] Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions
    Wubben, Thomas J.
    Johnson, Mark W.
    Sohn, Elliott H.
    Peairs, James J.
    Kay, Christine N.
    Kim, Stephen J.
    Gardner, Thomas W.
    Paulus, Yannis M.
    Zacks, David N.
    Steinle, Nathan C.
    Avery, Robert L.
    Berrocal, Maria H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 204 : 13 - 18
  • [48] Anti-Vascular Endothelial Growth Factor Injections for Diabetic Retinopathy: Continued Progress, More Questions
    Frank, Robert N.
    OPHTHALMOLOGY, 2019, 126 (05) : 721 - 722
  • [49] Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity
    Enriquez, Ana Bety
    Avery, Robert L.
    Baumal, Caroline R.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2020, 9 (04): : 358 - 368
  • [50] Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy
    Azad, Amee D.
    Chen, Evan M.
    Hinkle, John
    Rayess, Nadim
    Wu, David
    Eliott, Dean
    Mruthyunjaya, Prithvi
    Parikh, Ravi
    OPHTHALMOLOGY RETINA, 2021, 5 (04): : 390 - 392
12345